Rodedawg Intl - RWGI STOCK NEWS

Rodedawg International Industries (OTC: RWGI) has signed a Letter of Intent (LOI) to acquire a dispensary license in Costa Mesa, California, marking a significant expansion into retail dispensary markets. The Costa Mesa dispensary, compliant with state regulations, is strategically located to serve high-density and affluent areas, potentially generating $5 million to $7 million in annual revenue. CEO Chris Swartz highlighted the low capital entry due to seller financing for Tenant Improvements (TIs). This move aligns with RWGI's goals to enhance brand presence and grow through low-cost acquisitions, reinforcing their commitment to quality and customer satisfaction.

Rodedawg International Industries (OTC: RWGI) has launched a new product line called Nutrient CBD. This line consists of five products: 2 CBD Oil Tinctures, 1 CBD Roll-On, and 2 CBD Creams. These products are designed to meet the diverse needs of consumers seeking natural wellness solutions. The company emphasizes quality and innovation, using proprietary formulas and in-house manufacturing to ensure consistency. CEO Chris Swartz highlighted the growth potential in the CBD market, with U.S. sales expected to reach nearly $16 billion by 2026. The Nutrient CBD line complements Rodedawg's existing Elixicure Topical Pain Relief products and aims to drive revenue and increase shareholder value.

Rodedawg Ind. Intl., Inc. (OTC: RWGI) is expanding its Tree Moguls™ brand into retail cannabis dispensaries and cannabis delivery services, marking a significant milestone in the company's growth strategy. The expansion includes sales in Long Beach, Lake Elsinore, Costa Mesa, and Los Angeles, with delivery service in Orange County, CA, enhancing accessibility for consumers seeking top-quality cannabis products.

Rodedawg International Industries, Inc. (RWGI) has opened a new headquarters in Costa Mesa, California, signaling its expansion in the top cannabis market globally. The move demonstrates the company's commitment to growth and success, enhancing its ability to meet revenue targets and cater to rising product demand. The modern facility offers a conducive work environment for business acceleration and sets the stage for future milestones.

Rodedawg International Industries, Inc. (OTC: RWGI) has announced a significant 204% increase in revenues for the quarter ending March 31, 2024. CEO Chris Swartz expressed pride in the better-than-expected financial performance, attributing the success to strategic expansions in management, licenses, and manufacturing capabilities. The company plans to continue its growth trajectory and aims to surpass the annual revenue goal of 7 million through planned expansions and shareholder updates.

Rodedawg International Industries, Inc. announces new officers appointment for Elixicure, , marking its entry into the $11 billion topical pain relief market. Future Market Insights research projects a 5.6% CAGR growth in global topical pain relief demand, reaching $19 billion by 2034. Jeff Byrne and Don Dedo join as key executives to drive Elixicure's expansion and market presence, reflecting Rodedawg's commitment to growth and success in the industry.

Rodedawg International Industries, Inc. (OTC: RWGI) has achieved a significant milestone in its cannabis distribution licensing in Coachella, California. The company's subsidiary, Parabola Mgmt. , has upgraded its license to 'Record Complete' status, indicating a major step forward in revenue generation. CEO Chris Swartz is optimistic about the company's growth prospects for 2024, with plans for sales, acquisitions, and mergers to drive revenue expansion. The recent developments position Rodedawg for continued success and financial growth.

Rodedawg Intl. Ind, Inc. (OTC: RWGI) announces sales channel expansion in the cannabis industry, highlighting manufacturing capabilities and revenue growth. The company plans to cancel over 100 million outstanding shares to enhance shareholder value.

Rodedawg International Industries, Inc. (RWGI) has accelerated sales of hemp and cannabis derived isolates through a new manufacturing facility, leading to a 65% production increase. The company's internal investment aims to boost revenues, aligning with the growing Global Cannabis Extract Market projected to reach $21.6 Billion by 2026. Rodedawg plans to expand into multiple states as a multi-state operator, highlighting a strategic growth trajectory for shareholders.